Top 5 Safest Stocks For 2018

Kimberly-Clark Corp. (NYSE:KMB) has provided investors with reliable income increases for decades.

In fact, the company is one of the 51 Dividend Aristocrats, which can all be seen here.

Kimberly-Clark pays one of the safest dividends in the market, yields close to 3%, offers mid-single-digit payout growth and sells recession-resistant products.

All of these investment qualities are appealing for retired investors living on dividends.

Like many other large consumer brand multinationals however, Kimberly-Clark is battling foreign currency headwinds, slower growth in developed markets and an evolving competitive landscape.

Let’s take a closer look at Kimberly-Clark to see why it deserves to be a core position in our Top 20 Dividend Stocks portfolio.

Business overview

Kimberly-Clark has been in business since 1928 and has grown into one of the largest global manufacturers of various tissue and hygiene products.

Top 5 Safest Stocks For 2018: CASI Pharmaceuticals, Inc.(CASI)

Advisors’ Opinion:

  • [By Jim Robertson]

    US based but China focused small cap biopharmaceutical stockCASI Pharmaceuticals (NASDAQ: CASI) is up around 78% over the last three trading days on no apparent news on the newswires as the following chart illustrates:

  • [By Lisa Levin]

    CASI Pharmaceuticals Inc (NASDAQ: CASI) shares shot up 62 percent to $3.61 following disclosure company Director He Wei-Wu purchased 200,000 shares on October 5 and 6. The stock rallied 15 percent on no news during Tuesday's intraday session.

Top 5 Safest Stocks For 2018: Aimia Inc. (GAPFF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Aimia (OTCPK:GAPFF) (TSX: AIM, AIM.PR.A, AIM.PR.B, AIM.PR.C)

    As some background, we are intimately familiar with Aeroplan and Air Canada (OTCQX:ACDVF) not just as investors but as extraordinarily heavy consumers. As both an Air Canada top tier elite and Aeroplan top tier member I generate well in excess of 1.5 million Aeroplan miles annually, half from flying Air Canada and its partners and the other half from spending. As consumers we were concerned with Air Canada’s decision (though we expect more details to come out that will alleviate these concerns) but as investors we understand that the fundamental business model of mileage programs are incredibly attractive and that Aimia presents an incredibly rare and lucrative investment opportunity for the investor discerning enough to dig into the company.

Top 5 Safest Stocks For 2018: Sarepta Therapeutics, Inc.(SRPT)

Advisors’ Opinion:

  • [By Chris Lange]

    Sarepta Therapeutics, Inc. (NASDAQ: SRPT) saw its shares make a handy gain on Tuesday following its presentation at the JPMorgan Healthcare Conference. The companys Duchenne muscular dystrophy (DMD) drug, Exondys 51, generated better than expected sales clocking in at $5.4 million in the fourth quarter. Previously, this DMD treatment was approved by the FDA just as recently as September 2016.

  • [By Ben Levisohn]

    Skorney’s namesVertex Pharmaceuticals (VRTX),Sarepta Therapeutics (SRPT), and Curis (CRIS) his top biotech picks for 2017, while Ulz chosesBioMarin Pharmaceutical (BMRN) andParatek Pharmaceuticals (PRTK).

  • [By Lisa Levin]

    Sarepta Therapeutics Inc (NASDAQ: SRPT) shares were also up, gaining 16 percent to $47.52 following the announcement of positive results in its study for the treatment of Duchenne Muscular Dystrophy.

Top 5 Safest Stocks For 2018: Wendy’s/Arby’s Group Inc.(WEN)

Advisors’ Opinion:

  • [By Rich Duprey]

    And that’s despite Burger King and Wendy’s (NASDAQ:WEN) posting higher quarterly comps for years. The restaurant industry itself may be experiencing a slowdown, and fast food is falling with it after having been one of the few areas notching consistent gains, but it means McDonald’s growth was merely an aberration.

  • [By Michael Flannelly]

    KeyBanc analysts upgraded fast food restaurant operator The Wendy’s Co (WEN) on Friday, noting that the company has a number of positive developments that could provide a floor for the stock.

    The analysts upgraded WEN from “Underweight” to “Hold.”

    KeyBanc analyst Christopher O’Cull said, “We are raising our rating for The Wendy’s Company to HOLD as we believe: 1) Wendy’s SRS performance will diverge from the industry for the foreseeable future as new products are supported by more effective use of marketing dollars; 2) better menu and promotional management will lead to improved franchisee profitability (a focus of the new CFO Todd Penegor); and 3) the opportunity to extend the re-franchising program will provide a floor on the stock.”

    Wendy’s shares were up 7 cents, or 0.81%, during pre-market trading on Friday. The stock is up 57.01% year-to-date.

  • [By Monica Gerson]

    Analysts expect Wendys Co (NASDAQ: WEN) to report its quarterly earnings at $0.06 per share on revenue of $352.08 million. Wendys shares rose 1.79 percent to $11.38 in after-hours trading.

  • [By Monica Gerson]

    Wendys Co (NASDAQ: WEN) is expected to report its quarterly earnings at $0.06 per share on revenue of $352.08 million.

    Canadian Solar Inc. (NASDAQ: CSIQ) is estimated to report its quarterly earnings at $0.14 per share on revenue of $663.74 million.

  • [By Ben Levisohn]

    Upgrades had a big impact on stocks today. Wendy’s (WEN), for instance, gained 4.5% to $8.62 after being upgraded to Buy at Argus, while Cash America (CSH) advanced 3.7% to $44.32 after being upgraded to Market Outperform from Market Perform at JMP Securities. Walgreen (WAG) proved the big winner in the S&P 500 afterGoldman Sachs called the stock a Conviction Buy.

Top 5 Safest Stocks For 2018: Ambarella, Inc.(AMBA)

Advisors’ Opinion:

  • [By Leo Sun]

    Chipmaker Ambarella (NASDAQ:AMBA) produces image processing SoCs (systems on chips) for a wide range of products, including action cameras, dash cams, drones, security cameras, and augmented reality glasses. But it generates most of its direct OEM revenue from one customer — action camera maker GoPro (NASDAQ:GPRO).

  • [By Rick Munarriz]

    Ambarella (NASDAQ:AMBA) wasn’t as scintillating as NVIDIA last year, merely marching in place. However, the provider of video compression and image processing semiconductors has seen its stock pop ninefold since going public at $6 five years ago.

  • [By Kumar Abhishek]

    Ambarella (NASDAQ:AMBA) stock is currently testing its 50-day simple moving average support line. As can be seen in Ambarella’s Technical analysis charts, AMBA stock was in a strong downtrend, forming lowerlows and lower highs over the past six months. However, the trend changed after the stock formed a doublebottom pattern. Double bottom is a trend reversal pattern which indicates that the stock is likelyto go up. After forming the double bottom pattern, the stock rallied, gaining around 10%. However, the rally was brought to a halt after the 100-day and 200-day simple moving averages formed a death cross. A death cross occurs when a shorter period moving average cuts a longer period moving average from the top. It is a strong bearish signal. The death cross was accompanied by abearish crossover between MACD and signal line. Ambarella stock has been in a decline ever since.

  • [By Lisa Levin]

    Shares of Ambarella Inc (NASDAQ: AMBA) got a boost, shooting up 19 percent to $64.32 after the company reported stronger-than-expected results for its third quarter.

  • [By Chris Lange]

    Ambarella, Inc. (NASDAQ: AMBA) reported fiscal fourth quarter financial results after markets closed on Tuesday. The company posted $0.92 in earnings per share (EPS) and $87.5 million in revenue, versus consensus estimates from Thomson Reuters that called for $0.74 in EPS and $86.07 million in revenue. The same period from last year had $0.64 in EPS on $67.97 million in revenue.

  • [By Peter Graham]

    Ambarella, Inc. (AMBA) has been all over the map over the last few years. It has defied gravity both to the up and to the downside, and although today’s suggested short of the stock is strictly technical, we do believe its current share price has once again gotten a little out of line when you compare it to the rest of the markets’ valuation metrics right now.

Leave a Reply

Your email address will not be published. Required fields are marked *